Interestingly, treatment with R-115 increases the number of CD4+ and CD8+ T cells infiltrating into the tumor microenvironment, while the vast majority of CD4+ and CD8+ T cells in the R-LM113 treatment group accumulated at the edge of the tumors, indicating the effects of IL-12 [39]. This evidence concerns the gene CD8A and neoplasm.